The inaugural Healthcare Sensors Innovation event in Cambridge on 25-26 September will bring together the healthcare and electronics industry to explore opportunities in point of care diagnostics and continuous monitoring.
The event, which is exceeding registration expectations, addresses the needs and opportunities for faster diagnosis, remote monitoring and treatment and the opportunity for new revenue streams, alongside the progress of the enabling technologies including biosensors, flexible electronics, low power electronics and connectivity.
Attendees include AstraZeneca, GSK, Baxter Healthcare, Boston Scientific, Smith & Nephew, W.L. Gore and LifeScan.
Uniquely these organizations are brought together with those in electronics and electronics materials, including Analog Devices, Philips, STMicroelectronics, Samsung, Sun Chemical, Maxim Integrated, Molex, Nissha, Henkel, and many others.
Nadia Tsao, senior technology analyst who runs the Life Sciences research practice at IDTechEx, said: “The success of this event is down to its focus on two core growth areas: continuous monitoring and point-of-care diagnostics. With ageing populations, shortage of medical staff, and the need to rapidly diagnose and treat based on accurate measurement data, this event focuses on pragmatic applications of technology innovations that are occurring now, such as the $7.5 billion electronic skin patches market.”
The event will be held at Clare College, part of the University of Cambridge.
